Anki Malmborg

Working to commercialize science

[SenzaGen AB @SenzagenAb]

It is very promising that we already get orders for our new endpoint skin irritation. https://t.co/8ThxBAZODI
#invitro #skin #genomics

[SenzaGen AB @SenzagenAb]

We are pleased to announce a positive ESAC opinion on GARD™skin, paving the way for OECD validation. According to the positive opinion, ESAC recommends that OECD include GARD®skin on their list of internationally agreed test methods. https://t.co/qEClBTaVq2

[SenzaGen AB @SenzagenAb]

Excited to announce that another CRO has been trained on SenzaGen's GARD technology platform and is offering GARDskin and GARDair services. @mbresearch is deeply committed to their customers and is dedicated to offering the latest predictive and innovative test methods.
#invitro

[SenzaGen AB @SenzagenAb]

Interested in the GARDskin ring trial performed for OECD validation? Read the full article now available ahead of print with open access in Toxicological Sciences, Society of Toxicology (SOT). @SOToxicology, @ToxSci, @OUPAcademic #ToxSci, #Toxicology
https://t.co/3WvfmDqHcT

[Anki Malmborg @AnkiMalmborg]

Swedish influencer Margaux Dietz tests shampoo at SenzaGen https://t.co/e6nTPro3r7

[SenzaGen AB @SenzagenAb]

Thank you EUROFINS for a well planned Seminar on Human Safety and thank you all attendees for your interest during and after the GARD presentation! Looking forward to supporting your journey for safer products with the GARD technology. #humansafety #3Rs

[SenzaGen AB @SenzagenAb]

View live presentation today at by SenzaGen’s CEO Anki Malmborg Hager at event “Sverige fortsatt starkt för Life Science?” hosted by Financial Meetings Click on link for live presentation: https://t.co/hZ2p2GvPa4

[SenzaGen AB @SenzagenAb]

Great attendance and interest for the skin sensitization workshop yesterday at the University of Goiás, Brazil. Thank you to the Faculty of Pharmacy for organising and inviting SenzaGen to speak! #animalfree #3Rs #brazil #COSMETICS

[SenzaGen AB @SenzagenAb]

Don’t miss this new opportunity to join a free presentation on Sensitization testing using GARD™. The webinar forum gives you a good chance to ask questions after the presentation. We are very much looking forward to meeting you virtually!
https://t.co/HdYz5Ac2hm

[SenzaGen AB @SenzagenAb]

Seminarie idag i Riksdagen med bland andra @SenzagenAb @djurensratt @thebodyshop @CrueltyFreeIntl i kampanjen #foreveragainstanimaltesting Onödiga djurförsök. In vitro -tester är bättre #3R #AnimlaFree #PlaceBetterTesting https://t.co/x1J91B8Fus

[SenzaGen AB @SenzagenAb]

SenzaGen CEO, @AnkiMalmborg invited as key person to talk on non-animal methods at Swedish Parliament Breakfast seminar with @djurensratt @thebodyshop @Crueltyfreeinternational in the campaign #foreveragainstanimaltesting to push away from animal testing
https://t.co/ilnZc0gylp

[Jens Holm @holmjens]

Hoppfullt frukostseminarium i riksdagen för internationellt förbud mot djurtestad kosmetika. Med bla @birgittaohlsson @CamillaBjorkbom @AsaWestlund @Hagelstedt @ElinLudis @emmanohren #foreveragainstanimaltesting

[Djurskyddet Sverige @Djurskyddet]

Företaget Senza Gen använder celltester istället för djur för att testa allergiska reaktioner på hud. Djurförsöken hade en träffprocent 72%, celltesterna 94%. Så djurförsök är på väg att bli onödiga!

[SenzaGen AB @SenzagenAb]

Today; Anki Malmborg Hager, CEO presenting company developments and SenzaGen’s ongoing and planned activities for commercialization of the GARDplatform @VatorSecurities Unicorn Summit #listentosenzagen #investors https://t.co/d8j1GtSuCd

[SenzaGen AB @SenzagenAb]

SenzaGen CEO gives presentation to the King of Sweden during IVA's Royal Technology Mission @MediconVillage. Great interest in latest technologies and the commercialisation of good research.

[SenzaGen AB @SenzagenAb]

Dissertation day! -Andy Forreryd’s work on GARD for #chemical #sensitisation testing. We wish him all the best of luck today! #3R #GARD #animalfree

[SenzaGen AB @SenzagenAb]

Research by Lund Univeristy researchers on #GARDprotein published in Toxicology In Vitro https://t.co/Xs7vHXyjrF

[Mattias Öberg @ObergMattias]

Grattis Malin Lindstedt! Nytänkare i världsklass @UtanDjurforsok @SenzagenAb

[SenzaGen AB @SenzagenAb]

We welcome SenzaGen to our European growth market, Nasdaq First North, Adam Kostyál, SVP and Head of European listings at Nasdaq.

[SenzaGen AB @SenzagenAb]

@SenzagenAb and @AnkiMalmborg rings the bell to start trading in #SENZA stock @Nasdaq First North!!